4528 — Ono Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual cashflow statement for Ono Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	65,141	79,696	100,890	105,025	143,532
Depreciation
Non-Cash Items	3,405	3,439	-82	-19,596	-830
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-12,393	-23,192	-42,651	-41,321	-543
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	66,774	74,157	73,977	61,829	159,610
Capital Expenditures	-29,602	-22,445	-20,293	-12,277	-14,497
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-20,161	12,211	-37,293	18,315	-85,762
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-49,763	-10,234	-57,586	6,038	-100,259
Financing Cash Flow Items	-5	-4	-6	-4	-8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-22,279	-54,721	-24,754	-60,237	-32,484
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-5,292	9,023	-7,960	8,066	27,022